Company Analysis
Sign in

Oramed Pharmaceuticals Inc. (ORMP)

Nasdaq: ORMP · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2002
Full chart Alerts Compare
Grade5.3
◀ Past 6.0● Present 6.0▶ Future 4.3
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Aug 31, 2021Aug 31, 2020Aug 31, 2019Aug 31, 2018Aug 31, 2017
Report filedMar 26, 2026Mar 27, 2025Mar 6, 2024Mar 6, 2023·Nov 24, 2021Nov 24, 2020Nov 27, 2019Nov 28, 2018Nov 29, 2017
Revenue2,000,000·1,340,0002,703,000·2,703,0002,710,0002,703,0002,449,0002,456,000
Cost of revenue1,987,000······90,000-86,000187,000
Gross profit13,000·········
Research and development6,381,0006,324,0008,971,00027,639,000·20,989,00010,235,00013,522,00011,979,00010,281,000
General and administrative8,720,0006,457,0008,425,00013,811,000·5,937,0004,232,0003,722,0004,083,0002,759,000
Operating income-15,088,000-12,781,000-15,769,000-40,598,000·-24,223,000-11,757,000-14,631,000-13,527,000-10,771,000
Interest expense·853,0002,037,000·······
Interest and investment income2,373,0004,983,00010,000100,000······
Interest income (expense), net·4,128,0008,016,0003,473,000·130,000552,000909,000741,000657,000
Other income (expense), net-606,000-27,000r13,313·······
Total non-operating income (expense)89,454,000-2,286,00022,894,0002,934,000······
Income before income taxes75,324,000-15,920,0005,088,000-37,664,000··-11,511,000-14,055,000-12,727,000-10,080,000
Income tax expense11,308,0003,183,000·100,000···300,000·400,000
Income from continuing operations···100,000······
Net income including non-controlling interests64,016,000-19,103,000r5,525,000r-37,764,000·-22,989,000-11,511,000-14,355,000··
Net income to non-controlling interests-34,000-43,000r437,000r-1,203,000······
Net income64,050,000-19,060,000r5,088,000r-36,561,000·-22,989,000-11,511,000-14,355,000-12,727,000-10,480,000
Net income to common shareholders63,242,000-19,060,000·-36,561,000·22,989,00011,511,000···
Earnings per share, basic1.53-0.480.14-0.94r······
Earnings per share, diluted1.50-0.480.14-0.94r······
Earnings per share, basic and diluted·····0.780.560.820.860.79
Weighted average shares, basic41,402,99740,850,446r40,315,06838,997,649······
Weighted average shares, diluted42,418,64440,850,446r40,566,90138,997,649······
Weighted average shares, basic and diluted·····28,469,06820,532,34717,454,48914,882,35613,309,372
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InterestIncomeOther
Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton ORMP · research, not advice